Merck & Co., Inc. 13D and 13G filings for Yumanity Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-04 2:28 pm Purchase |
2020-12-22 | 13G | Yumanity Therapeutics, Inc. YMTX |
Merck & Co. Inc. MRK |
75,286 5.200% |
75,286 (New Position) |
Filing |